Global Continuous Glucose Monitoring Systems Market Size By Component, By End-User, By Geographic Scope And Forecast -Global Trends and Forecasts(2025 to 2034)
Description
Continuous Glucose Monitoring Systems Market Size And Forecast
According to Factview Research, Global Continuous Glucose Monitoring Systems Market was valued at USD 4.33 Billion in 2025 and is projected to reach USD 13.21 Billion by 2027, growing at a CAGR of 13.1% from 2020 to 2027.
Global Continuous Glucose Monitoring Systems Market Outlook
In the report, the market outlook section mainly encompasses fundamental dynamics of the market which include drivers, restraints, opportunities and challenges faced by the industry. Drivers and restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market.
Factview Research narrows down the available data using primary sources to validate the data and use it in compiling a full-fledged market research study. The report contains a quantitative and qualitative estimation of market elements that interests the client. The Global Continuous Glucose Monitoring Systems Market is mainly bifurcated into sub-segments which can provide classified data regarding the latest trends in the market.
Global Continuous Glucose Monitoring Systems Market Competitive Landscape
The Global Continuous Glucose Monitoring Systems Market study report will provide a valuable insight with an emphasis on the Global market including some of the major players such as Medtronic PLC, Sano Intelligence, Biolinq, Echo Therapeutics, Pfizer, Baxter, Animas.
According to Factview Research, Global Continuous Glucose Monitoring Systems Market was valued at USD 4.33 Billion in 2025 and is projected to reach USD 13.21 Billion by 2027, growing at a CAGR of 13.1% from 2020 to 2027.
Global Continuous Glucose Monitoring Systems Market Outlook
In the report, the market outlook section mainly encompasses fundamental dynamics of the market which include drivers, restraints, opportunities and challenges faced by the industry. Drivers and restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market.
Factview Research narrows down the available data using primary sources to validate the data and use it in compiling a full-fledged market research study. The report contains a quantitative and qualitative estimation of market elements that interests the client. The Global Continuous Glucose Monitoring Systems Market is mainly bifurcated into sub-segments which can provide classified data regarding the latest trends in the market.
Global Continuous Glucose Monitoring Systems Market Competitive Landscape
The Global Continuous Glucose Monitoring Systems Market study report will provide a valuable insight with an emphasis on the Global market including some of the major players such as Medtronic PLC, Sano Intelligence, Biolinq, Echo Therapeutics, Pfizer, Baxter, Animas.
Table of Contents
202 Pages
- 1 Introduction Of Global Continuous Glucose Monitoring Systems Market
- 1.1 Overview Of The Market
- 1.2 Scope Of Report
- 1.3 Assumptions
- 2 Executive Summary
- 3 Research Methodology Of Factview Research
- 3.1 Data Mining
- 3.2 Validation
- 3.3 Primary Interviews
- 3.4 List Of Data Sources
- 4 Global Continuous Glucose Monitoring Systems Market Outlook
- 4.1 Overview
- 4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
- 4.3 Porters Five Force Model
- 4.4 Value Chain Analysis
- 5 Global Continuous Glucose Monitoring Systems Market, By Component
- 5.1 Overview
- 5.2 Transmitters And Receivers
- 5.3 Sensors
- 5.4 Insulin Pumps
- 6 Global Continuous Glucose Monitoring Systems Market, By End-user
- 6.1 Overview
- 6.2 Hospitals
- 6.3 Home Healthcare Settings
- 6.4 Others
- 7 Global Continuous Glucose Monitoring Systems Market, By Geography
- 7.1 Overview
- 7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.2.3 Mexico
- 7.3 Europe
- 7.3.1 Germany
- 7.3.2 U.K.
- 7.3.3 France
- 7.3.4 Rest Of Europe
- 7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Rest Of Asia Pacific
- 7.5 Rest Of The World
- 7.5.1 Latin America
- 7.5.2 Middle East
- 8 Global Continuous Glucose Monitoring Systems Market Competitive Landscape
- 8.1 Overview
- 8.2 Company Market Ranking
- 8.3 Key Development Strategies
- 9 Company Profiles
- 9.1 Abbott Laboratories Inc.
- 9.1.1 Overview
- 9.1.2 Financial Performance
- 9.1.3 Product Outlook
- 9.1.4 Key Developments
- 9.2 Dexcom Inc
- 9.2.1 Overview
- 9.2.2 Financial Performance
- 9.2.3 Product Outlook
- 9.2.4 Key Developments
- 9.3 Medtronic Plc
- 9.3.1 Overview
- 9.3.2 Financial Performance
- 9.3.3 Product Outlook
- 9.3.4 Key Developments
- 9.4 Sano Intelligence
- 9.4.1 Overview
- 9.4.2 Financial Performance
- 9.4.3 Product Outlook
- 9.4.4 Key Developments
- 9.5 Biolinq
- 9.5.1 Overview
- 9.5.2 Financial Performance
- 9.5.3 Product Outlook
- 9.5.4 Key Developments
- 9.6 Echo Therapeutics
- 9.6.1 Overview
- 9.6.2 Financial Performance
- 9.6.3 Product Outlook
- 9.6.4 Key Developments
- 9.7 Pfizer
- 9.7.1 Overview
- 9.7.2 Financial Performance
- 9.7.3 Product Outlook
- 9.7.4 Key Developments
- 10 Appendix
- 10.1 Related Research
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.



